Development of the NIH PROMIS® Sexual Function and Satisfaction Measures in Patients with Cancer
- 1 February 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 10 (Supplement), 43-52
- https://doi.org/10.1111/j.1743-6109.2012.02995.x
Abstract
We describe the development and validation of the Patient‐Reported Outcomes Measurement Information System® Sexual Function and Satisfaction (PROMIS® SexFS; National Institutes of Health) measures, version 1.0, for cancer populations. To develop a customizable self‐report measure of sexual function and satisfaction as part of the U.S. National Institutes of Health PROMIS Network. Our multidisciplinary working group followed a comprehensive protocol for developing psychometrically robust patient‐reported outcome measures including qualitative (scale development) and quantitative (psychometric evaluation) development. We performed an extensive literature review, conducted 16 focus groups with cancer patients and multiple discussions with clinicians, and evaluated candidate items in cognitive testing with patients. We administered items to 819 cancer patients. Items were calibrated using item‐response theory and evaluated for reliability and validity. The PROMIS SexFS measures, version 1.0, include 81 items in 11 domains: Interest in Sexual Activity, Lubrication, Vaginal Discomfort, Erectile Function, Global Satisfaction with Sex Life, Orgasm, Anal Discomfort, Therapeutic Aids, Sexual Activities, Interfering Factors, and Screener Questions. In addition to content validity (patients indicate that items cover important aspects of their experiences) and face validity (patients indicate that items measure sexual function and satisfaction), the measure shows evidence for discriminant validity (domains discriminate between groups expected to be different) and convergent validity (strong correlations between scores on PROMIS and scores on conceptually similar older measures of sexual function), as well as favorable test–retest reliability among people not expected to change (interclass correlations from two administrations of the instrument, 1 month apart). The PROMIS SexFS offers researchers a reliable and valid set of tools to measure self‐reported sexual function and satisfaction among diverse men and women. The measures are customizable; researchers can select the relevant domains and items comprising those domains for their study. Flynn KE, Lin L, Cyranowski JM, Reeve BB, Reese JB, Jeffery DD, Smith AW, Porter LS, Dombeck CB, Bruner DW, Keefe FJ, and Weinfurt KP. Development of the NIH PROMIS® Sexual Function and Satisfaction measures in patients with cancer. J Sex Med 2013;10(suppl 1):43–52.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR052186)
This publication has 20 references indexed in Scilit:
- Psychosexual Functioning and Body Image Following a Diagnosis of Ductal Carcinoma In SituThe Journal of Sexual Medicine, 2013
- The Relationships Between Preoperative Sexual Desire and Quality of Life Following Radical Prostatectomy: A 5-Year Follow-Up StudyThe Journal of Sexual Medicine, 2012
- Sexual functioning along the cancer continuum: focus group results from the Patient‐Reported Outcomes Measurement Information System (PROMIS®)Psycho‐Oncology, 2011
- Using cognitive interviews to evaluate items for measuring sexual functioning across cancer populations: improvements and remaining challengesQuality of Life Research, 2009
- Initial report of the cancer Patient‐Reported Outcomes Measurement Information System (PROMIS) sexual function committeeCancer, 2009
- Is Abuse Causally Related to Urologic Symptoms? Results from the Boston Area Community Health (BACH) SurveyEuropean Urology, 2007
- The Patient-Reported Outcomes Measurement Information System (PROMIS)Medical Care, 2007
- Evaluation of Item CandidatesMedical Care, 2007
- Sexual sequelae of general medical disordersThe Lancet, 2007
- The UCLA Prostate Cancer IndexMedical Care, 1998